Bolt Biotherapeutics BOLT

$ 0.57 0.77%

Quarterly report 2024-Q3
added 11-12-2024

Bolt Biotherapeutics Financial Statements 2011-2024 | BOLT

Annual Financial Statements Bolt Biotherapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	43.9 M	50.8 M	127 M	-	-	-	-	-	-	-	-	-	-
Shares	37.8 M	37.4 M	33.2 M	-	-	-	-	-	-	-	-	-	-
Historical Prices	1.16	1.36	3.84	-	-	-	-	-	-	-	-	-	-
Net Income	-69.2 M	-88.1 M	-98.6 M	-	-30.5 M	-11.6 M	-	-	-	-	-	-	-
Revenue	7.88 M	5.73 M	1.26 M	231 K	215 K	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	231 K	-	-	-	-	-	-	-	-	-
Operating Income	-76.2 M	-90.3 M	-92.8 M	-49.2 M	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-74.3 M	-88.7 M	-91.6 M	-48.6 M	-30.6 M	-11.3 M	-	-	-	-	-	-	-
Operating Expenses	84.1 M	96 M	94 M	49.4 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	22.5 M	22.9 M	18.4 M	9.06 M	5.18 M	2.21 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Bolt Biotherapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	38.3 M	38.1 M	38.1 M	38.1 M	37.9 M	37.8 M	37.7 M	37.8 M	37.5 M	37.3 M	37.1 M	37.4 M	37.2 M	36.6 M	21.5 M	2.13 M	1.98 M	1.94 M	1.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-15.2 M	-21.2 M	-10.8 M	-	-16.3 M	-18.1 M	-17 M	-	-21.8 M	-22.7 M	-23.7 M	-	-23.4 M	-23.6 M	-24.5 M	-	-10 M	-11.1 M	-8.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	1.14 M	1.28 M	5.27 M	-	2.53 M	1.43 M	1.83 M	-	2.11 M	1.39 M	813 K	-	752 K	-	-	-	231 K	67 K	164 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-16.4 M	-22.6 M	-17.1 M	-	-18.2 M	-19.8 M	-18.4 M	-	-22.3 M	-23.1 M	-23.9 M	-	-23.5 M	-23.8 M	-18.4 M	-	-12.4 M	-11.1 M	-8.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-15.9 M	-22.2 M	-16.6 M	-	-17.7 M	-19.4 M	-17.9 M	-	-21.9 M	-22.7 M	-23.5 M	-	-22.7 M	-23.2 M	-18.2 M	-	-12 M	-10.9 M	-8.64 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	17.6 M	23.9 M	22.4 M	-	20.7 M	21.3 M	20.2 M	-	24.5 M	24.5 M	24.7 M	-	24.3 M	23.8 M	18.4 M	-	12.4 M	11.2 M	8.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.8 M	4.87 M	5.84 M	-	5.76 M	5.62 M	5.62 M	-	5.48 M	5.53 M	6.3 M	-	4.94 M	4.05 M	4.3 M	-	2.86 M	2.01 M	2.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency